Edition:
United Kingdom

Rohto Pharmaceutical Co Ltd (4527.T)

4527.T on Tokyo Stock Exchange

3,090JPY
15 Dec 2017
Change (% chg)

¥-30 (-0.96%)
Prev Close
¥3,120
Open
¥3,125
Day's High
¥3,125
Day's Low
¥3,065
Volume
267,700
Avg. Vol
436,676
52-wk High
¥3,130
52-wk Low
¥1,782

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -- March 16 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 1 1 1
(3) HOLD 5 5 5 5
(4) UNDERPERFORM 1 1 1 1
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.88 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 1 41,958.00 41,958.00 41,958.00 --
Quarter Ending Mar-18 1 43,930.00 43,930.00 43,930.00 --
Year Ending Mar-17 6 153,850.00 155,000.00 152,100.00 --
Year Ending Mar-18 7 165,314.00 167,500.00 160,200.00 160,840.00
Year Ending Mar-19 7 171,529.00 179,800.00 163,800.00 165,200.00
Earnings (per share)
Year Ending Mar-17 7 77.40 87.95 70.30 --
Year Ending Mar-18 8 100.21 113.20 95.70 80.23
Year Ending Mar-19 8 107.82 130.70 97.40 86.01
LT Growth Rate (%) 1 11.53 11.53 11.53 6.51

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 38,540.00 42,661.00 4,121.00 10.69
Quarter Ending Mar-17 41,958.00 43,177.00 1,219.00 2.91
Quarter Ending Dec-16 37,544.00 40,124.00 2,580.00 6.87
Quarter Ending Sep-16 41,215.00 38,419.00 2,796.00 6.78
Quarter Ending Mar-16 45,800.00 46,692.00 892.00 1.95

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-17 41,958.00 -- -- -- --
Quarter Ending Mar-18 43,930.00 43,930.00 43,930.00 43,930.00 --
Year Ending Mar-17 153,850.00 -- -- -- --
Year Ending Mar-18 165,314.00 165,314.00 163,200.00 161,317.00 160,840.00
Year Ending Mar-19 171,529.00 171,529.00 167,983.00 165,817.00 165,200.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-17 -- -- -- --
Quarter Ending Mar-18 0 0 0 0
Year Ending Mar-17 -- -- -- --
Year Ending Mar-18 0 0 2 0
Year Ending Mar-19 0 0 2 0
Earnings